qs_id,statement_number,statement
QS100,1,Adults under 85 years with an estimated increased risk of cardiovascular disease (CVD) are offered a full formal risk assessment using the QRISK2 tool.
QS100,2,Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more are assessed for secondary causes before any offer of statin therapy.
QS100,3,Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more receive advice on lifestyle changes before any offer of statin therapy.
QS100,4,"Adults with a 10‑year risk of cardiovascular disease (CVD) of 10% or more for whom lifestyle changes are ineffective or inappropriate, discuss the risks and benefits of starting statin therapy with their healthcare professional."
QS100,5,Adults choosing statin therapy for the primary prevention of cardiovascular disease (CVD) are offered atorvastatin 20 mg.
QS100,6,Adults with newly diagnosed cardiovascular disease (CVD) are offered atorvastatin 80 mg.
QS100,7,Adults on a high‑intensity statin who have side effects are offered a lower dose or an alternative statin.
QS100,8,Adults on a high‑intensity statin have a repeat measurement of lipids and liver transaminases after 3 months of treatment.
QS100,9,[Placeholder: Identifying people with an estimated increased risk]
